Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Clinical trial NCT05224531 · COMPLETED

Trial details

NCT number: NCT05224531
Sponsor: Cereno Scientific AB
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2022-05-05
Primary completion: 2024-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.